<?xml version="1.0" encoding="UTF-8"?>
<TEI xml:space="preserve" xmlns="http://www.tei-c.org/ns/1.0" 
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" 
xsi:schemaLocation="http://www.tei-c.org/ns/1.0 /home/lopez/grobid/grobid-home/schemas/xsd/Grobid.xsd"
 xmlns:xlink="http://www.w3.org/1999/xlink">
	<teiHeader xml:lang="en">
		<fileDesc>
			<titleStmt>
				<title level="a" type="main">Application of31P MR Spectroscopy to the Brain Tumors</title>
			</titleStmt>
			<publicationStmt>
				<publisher>The Korean Society of Radiology (KAMJE)</publisher>
				<availability status="unknown"><p>Copyright The Korean Society of Radiology (KAMJE)</p>
				</availability>
				<date type="published" when="2013">2013</date>
			</publicationStmt>
			<sourceDesc>
				<biblStruct>
					<analytic>
						<author>
							<persName xmlns="http://www.tei-c.org/ns/1.0"><roleName>MD</roleName><forename type="first">Dong-Ho</forename><surname>Ha</surname></persName>
						</author>
						<author>
							<persName xmlns="http://www.tei-c.org/ns/1.0"><roleName>MD</roleName><forename type="first">Sunseob</forename><surname>Choi</surname></persName>
						</author>
						<author>
							<persName xmlns="http://www.tei-c.org/ns/1.0"><roleName>MD</roleName><forename type="first">Jong</forename><forename type="middle">Young</forename><surname>Oh</surname></persName>
						</author>
						<author>
							<persName xmlns="http://www.tei-c.org/ns/1.0"><roleName>MD</roleName><forename type="first">Seong</forename><forename type="middle">Kuk</forename><surname>Yoon</surname></persName>
						</author>
						<author>
							<persName xmlns="http://www.tei-c.org/ns/1.0"><roleName>MD</roleName><forename type="first">Myong</forename><forename type="middle">Jin</forename><surname>Kang</surname></persName>
						</author>
						<author>
							<persName xmlns="http://www.tei-c.org/ns/1.0"><roleName>MD</roleName><forename type="first">Ki-Uk</forename><surname>Kim</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">College of Medicine</orgName>
								<orgName type="institution" key="instit1">Neurosurgery</orgName>
								<orgName type="institution" key="instit2">Dong-A University</orgName>
								<address>
									<postCode>602-715</postCode>
									<settlement>Busan</settlement>
									<country key="KR">Korea</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff1">
								<orgName type="department">Department of Radiology, College of Medicine</orgName>
								<address>
									<addrLine>Dong-A University, 26 Daesingongwon-ro, Seo-gu</addrLine>
									<postCode>602-715</postCode>
									<settlement>Busan</settlement>
									<country key="KR">Korea</country>
								</address>
							</affiliation>
						</author>
						<title level="a" type="main">Application of31P MR Spectroscopy to the Brain Tumors</title>
					</analytic>
					<monogr>
						<title level="j" type="main">Korean Journal of Radiology</title>
						<title level="j" type="abbrev">Korean J Radiol</title>
						<idno type="ISSN">1229-6929</idno>
						<idno type="eISSN">2005-8330</idno>
						<imprint>
							<publisher>The Korean Society of Radiology (KAMJE)</publisher>
							<biblScope unit="volume">14</biblScope>
							<biblScope unit="issue">3</biblScope>
							<biblScope unit="page">477</biblScope>
							<date type="published" when="2013" />
						</imprint>
					</monogr>
					<idno type="DOI">10.3348/kjr.2013.14.3.477</idno>
					<idno type="PMID">23690717</idno>
					<idno type="PMCID">PMC3655304</idno>
					<ptr type="open-access" target="http://synapse.koreamed.org/Synapse/Data/PDFData/0068KJR/kjr-14-477.pdf" />
					<note type="submission">Received May 31, 2012; accepted after revision September 4, 2012.</note>
				</biblStruct>
			</sourceDesc>
		</fileDesc>
		<encodingDesc>
			<appInfo>
				<application version="0.6.2-SNAPSHOT" ident="GROBID" when="2020-08-13T22:05+0000">
					<desc>GROBID - A machine learning software for extracting information from scholarly documents</desc>
					<ref target="https://github.com/kermitt2/grobid"/>
				</application>
			</appInfo>
		</encodingDesc>
		<profileDesc>
			<textClass>
				<keywords>
					<term>Magnetic resonance imaging</term>
					<term>MRS</term>
					<term>Brain</term>
					<term>Tumor</term>
				</keywords>
			</textClass>
			<abstract>
				<p>Objective: To evaluate the clinical feasibility and obtain useful parameters of 31 P magnetic resonance spectroscopy (MRS) study for making the differential diagnosis of brain tumors. Materials and Methods: Twenty-eight patients with brain tumorous lesions (22 cases of brain tumor and 6 cases of abscess) and 11 normal volunteers were included. The patients were classified into the astrocytoma group, lymphoma group, metastasis group and the abscess group. We obtained the intracellular pH and the metabolite ratios of phosphomonoesters/ phosophodiesters</p>
			</abstract>
		</profileDesc>
	</teiHeader>
	<text xml:lang="en">
		<body>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>INTRODUCTION</head><p>Magnetic resonance spectroscopy (MRS) has been used to identify the characteristics of cancer cells and to evaluate the response of cancer cells to the targeted treatment, noninvasively, by MR signal <ref type="bibr" target="#b0">(1)</ref>. The commonly utilized elements for MRS are 1 H, 31 P, <ref type="bibr" target="#b12">13</ref> C, <ref type="bibr" target="#b18">19</ref> F, <ref type="bibr" target="#b22">23</ref> NA and 2 H (2). The phosphorous metabolites detected by 31 P MRS, such as adenosine triphosphate (ATP), phosphocreatine (PCr), inorganic phosphate (Pi), phosphomonoesters (PME), and phosophodiesters (PDE), provide the information of the intracellular pH, the cellular energy metabolism, and the phospholipid metabolism <ref type="bibr" target="#b2">(3,</ref><ref type="bibr" target="#b3">4)</ref>.</p><p>In brain tumors, 31 P MRS showed variable changes of the phospholipid metabolism. The intracellular pH and some phosphorous metabolite ratios, such as PME/PDE, PME/ Pi, PDE/Pi, PME/ATP, PDE/ATP, PME/PCr and etc, were considered to be potential markers of tumors <ref type="bibr" target="#b2">(3,</ref><ref type="bibr" target="#b4">(5)</ref><ref type="bibr" target="#b5">(6)</ref><ref type="bibr" target="#b6">(7)</ref><ref type="bibr" target="#b7">(8)</ref>.</p><p>http://dx.doi.org/10.3348/kjr.2013.14.3.477 However, there are several limitations. There have been reports that 31 P MRS has a limited role for diagnosing cancer, making the differential diagnosis of specific tumor types and assessing the degree of malignancy <ref type="bibr" target="#b2">(3,</ref><ref type="bibr" target="#b5">6,</ref><ref type="bibr" target="#b7">8)</ref>. Moreover, even though 31 P MRS showed good reproducibility among different institutions <ref type="bibr" target="#b8">(9)</ref>, many of the results did not match well with other results. The most useful metabolite ratios have not yet been agreed on. Furthermore, long scan time and the complexity of the post-processing procedure make other limitations to apply 31 P MRS to patients.</p><p>We performed a localized 31 P MRS study on brain tumorous lesions with a relatively short scan time and evaluate the useful parameters of 31 P MRS study to differentiate the brain tumors.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>MATERIALS AND METHODS</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Patients</head><p>From October 2006 to May 2010, we prospectively performed MRS study on 47 patients who had brain tumorous lesions detected on MRI. Forty five cases of brain tumor and abscess were confirmed by biopsy or open surgery.</p><p>We excluded the brain lesion that had large hemorrhage on the T1 weighted MR images. We also excluded the other brain lesions for the following reasons by a consensus of two radiologists: 1) the size of brain lesions on MRI was too small to evaluate the MRS spectrum, lesser than 3 cm in diameter, 2) two post-radiation states, 3) local recurrence after chemotherapy or radiation therapy, 4) rare cases such as pineal meningioma and dural hemangioblastoma, 5) one case of pilocytic astrocytoma that had a large cyst, was excluded from the cases of astocytoma, and 6) one case of purely cystic abscess that contained entirely cystic portion on the fluid-attenuated inversion recovery images.</p><p>As a result, we included 22 cases of brain tumor and 6 cases of abscess. The pathologically confirmed brain tumor and abscess were classified into the 13 cases of astrocytoma (age range: 16-74, mean age: 42.8, 7 males and 4 females, 4 cases of low grade astrocytoma and 9 cases of high grade astrocytoma), 4 cases of lymphoma (age range: 56-69, mean age: 64.0, 3 males and 1 female), 5 cases of metastasis (age range: 60-80, mean age: 71.8, 1 male and 4 females) and 6 cases of abscess (age range: 30-73, mean age: 54.5, 3 males and 3 females) ( <ref type="figure" target="#fig_1">Fig. 1</ref>). All 4 cases of lymphoma were large B cell lymphoma. None of these patients received therapy before the MRS analysis.</p><p>We also obtained the MRS spectra of 11 normal volunteers as the control group (age range: 23-40 years, mean age: 30.2, 7 males and 4 females). They did not have any specific medical history, such as migraine, recent infarct or trauma. The MRS of normal volunteers was obtained at the thalamus area to avoid the artifact from subcutaneous fat and magnetic inhomogeneity due to a peripheral location.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>MRS Protocol</head><p>We performed 31 P MRS on a 1.5 T GE scanner (Signa; GE Medial System, Milwaukee, WI, USA) with a flexible 31 P transmit/receive coil, operating at 25.85 MHz. This coil contained a blocking circuit to prevent the reception of signals at the hydrogen frequency (63.86 MHz). The patient's head was wrapped with the flexible surface phosphorus coil and placed in the hydrogen head coil for  For localization of a region of interest (ROI), the T2 weighted fast spin-echo sequences in two different slice orientations were performed. Then, automated 1 H shimming was done to obtain the homogeneity of the ROI by using the point resolved spectroscopy sequence pulse sequence.</p><p>For 31 P spectroscopy, the free induction decay (FID) 2 dimensional (2D) chemical shift imaging (CSI) sequence was carried out in an axial plane. The field of view was 3 x 3 x 3 cm, and the volume was 27 mL. The following parameters were used, Nex: 8, scan number: 128, spectral width: 2500 Hz, and acquired data points: 2048.</p><p>The 31 P spectra were post-processed using an automated procedure developed in SAGE (GE Medical Systems, Fremont, CA, USA). The obtained FID signal was displayed as a spectrum, following 2D CSI reconstruction with a magnitude channel. After using the 6 Hz exponential line broadening, we obtained the MR spectra that were assigned on the basis of prior assignment, such as PME, Pi, PDE, PCr and ATP. The chemical shift in the 31 P MRS referred to the position of PCr (δ = 0.00 ppm). The intracelluar pH of the lesions was calculated by using the chemical shift of Pi relative to PCr, with the formula taken from Ng et al. <ref type="bibr" target="#b9">(10)</ref>  <ref type="figure">(Fig. 2)</ref>. The integral of each of the phosphorous metabolites, such as ATP, PCr, Pi, PME and PDE, was measured. The following metabolite ratios of PME/PDE, PME/Pi, PDE/Pi, PME/ATP, PDE/ATP, PME/PCr, PDE/PCr, PCr/ATP, PCr/Pi and ATP/Pi were calculated from the measured values (Figs. 3-5).</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Statistical Analysis</head><p>We compared the mean values of the intracellular pH and the metabolite ratios between the normal control group and the brain tumor group by using the Mann-Whitney U test.</p><p>The Kruskal-Wallis test was used for obtaining the statistical significant parameter between the each brain lesion. Additionally, multiple comparisons of each brain lesions were also carried out using the Dunn test.</p><p>For comparison between the low grade astrocytoma group and high grade astocytoma group, and between the brain tumor group and the abscess group, the mean values of the intracellular pH and the metabolite ratios were also compared by using the Mann-Whitney U test.</p><p>A p value of less than 0.05 was considered significant. The statistical analysis was performed by using Statistical Package for the Social Sciences software (version 19.0, Chicago, IL, USA).</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>RESULTS</head><p>The average scan time for 31 P MRS was 6 minutes 36 seconds. Total scan time was 15 minutes, including the scanning for localization. All patients were tolerable to obtain the MR imaging and the MR spectrum in a study. The pattern of the spectrum or chemical shift frequency of each metabolite was very similar in each group.</p><p>The intracellular pH in the normal control group was calculated as 7.07 ± 0.10 ( <ref type="table" target="#tab_1">Table 1)</ref>. These values were slightly higher than those of the previous reported values in a healthy volunteer group <ref type="bibr" target="#b10">(11,</ref><ref type="bibr" target="#b11">12)</ref>. The brain tumors had a tendency of alkalization at a pH = 7.28 ± 0.27 (p value, 0.090) ( <ref type="table" target="#tab_1">Table 1</ref>). The PME/PDE ratio in the brain tumor group (0.57 ± 0.11) showed a significant increase compared to that in the control group (0.47 ± 0.07) (p value, 0.012).</p><p>The intracellular pH between each brain lesion groups did not show a statistically significant difference by using the Kruskal-Wallis test ( <ref type="table" target="#tab_2">Table 2)</ref>. We also obtained statistical significance of the intracellular pH between the normal control group and each brain lesions by using the Mann-Whitney U test. The lymphoma had a mean pH of 7.45 ± 0.32 and this represents significant alkalization, compared to the normal control group (p value, 0.013). The mean value of pH in the metastasis (7.48 ± 0.56) was markedly higher than in the normal brain, but the difference was statistically insignificant (p value, 0.112). The pH in the kjronline.org metastasis showed a wide standard deviation. Two cases of metastasis showed a lower pH value (below 6.90) than that in the normal brain. Three cases of metastasis showed marked alkalization. The pH in the brain abscess (7.56 ± 0.64) also showed a wide standard deviation, compared to that in the control group (p value, 0.159).</p><p>The ratios of PME/PDE, PDE/Pi, PME/PCr and PDE/PCr showed statistical significant differences between each brain lesion groups by using the Kruskal-Wallis test <ref type="table" target="#tab_2">(Table  2)</ref>. We used the Dunn procedure for comparison of each group and a p value of less than 0.005 was considered significant. The PME/PDE ratio in the astrocyoma group (0.56 ± 0.10) was significantly higher than that in the control group (0.47 ± 0.07) (p value, 0.003). The PME/PDE ratio in the lymphoma group (0.60 ± 0.15) was higher than that in the control group, but it had a wide standard deviation (p value, 0.117). The mean value of the PME/PDE ratio in metastasis (0.68 ± 0.19) was significantly higher than that in the control group (p value, 0.003). The abscess group showed a higher mean value of the PME/PDE ratio (0.65 ± 0.32) with a wide standard deviation than that in control group, statistically insignificant (p value, 0.366).</p><p>The PDE/Pi ratio in the lymphoma group (2.57 ± 0.60) was significantly lower than that in the control group (3.44 ± 0.49) (p value, 0.002). The PDE/Pi ratio in lymphoma was lower than that in astrocytoma (3.27 ± 0.62), but statistically insignificant (p value, 0.052). The PME/PCr ratio in the astrocyoma (0.43 ± 0.11) was significantly kjronline.org higher than that in the control group (0.34 ± 0.07) and in the lymphoma group (0.30 ± 0.08) (p value, 0.004, 0.003, respectively). The PME/PCr in lymphoma was also reduced compared to that of the control group, although the difference was statistically insignificant (p value, 0.151). The PDE/PCr ratio in lymphoma (0.51 ± 0.16) was significantly lower than that in the astrocytoma group (0.77 ± 0.18) (p value, 0.002). The PDE/PCr ratio in the lymphoma group was reduced compared to that of the control group (0.75 ± 0.20), but the statistically insignificant p value was observed (0.068).</p><p>There was no significant parameter between the low grade astrocytoma and high grade astrocytoma ( <ref type="table">Table 3</ref>). All the parameters of the metabolite ratios did not show significant differences between the brain tumor and the abscess <ref type="table">(Table 3)</ref>.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>DISCUSSION</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>31</head><p>P magnetic resonance spectroscopy can monitor the intracellular pH in living systems by using the chemical shifts of various phosphorous compounds <ref type="bibr" target="#b12">(13)</ref>. We obtained the intracellular pH by using the chemical shift of endogeneous Pi. The microenvironment within solid tumors displays acidic and hypoxic physiochemical alterations <ref type="bibr" target="#b13">(14,</ref><ref type="bibr" target="#b14">15)</ref>. Contrary to the assumption that tumor cells have acidic metabolism, measurements of human and animal tumor pH using 31 P MRS reported neutral-to-alkaline values <ref type="bibr" target="#b15">(16)</ref>. As reported in various studies, the pH of brain tumors was significantly higher than that of the normal brain tissue <ref type="bibr" target="#b16">(17,</ref><ref type="bibr" target="#b17">18)</ref>.  In our study, the brain tumor had a tendency of alkalization. The pH of astrocytoma was slightly higher than that of the normal brain. In lymphoma, the pH was significantly higher than that in the normal brain. The pH in the abscesses and metastatic lesions was clearly higher than that in the normal brain, but the pH was not statistically different due to the large scatter of data. We suspected that this was caused by the heterogenous nature of the lesions.</p><p>The phosphorous metabolites, detected by 31 P MRS, can be used for providing the information of the phospholipid metabolism. The measuring of the absolute concentration of phosphorous metabolites is the ultimate goal of the 31 P MRS study. However, there are various limitations. The obtained integral of each phosphorous metabolites (PME, PDE, PCr, Pi, ATP) on the spectrum were considered as the relative concentration of metabolites in the lesion <ref type="bibr" target="#b3">(4)</ref>. The difficulty of appropriate calibration, the sensitivity of the surface coils, J-coupling, low concentration of metabolites and variations from other various correction factors also contribute to the variations of quantification of phosphorus metabolites. The use of metabolite ratios could reduce these variations. A number of researchers have used various ratios of metabolic components, such as PME/ATP, PDE/ATP, PDE/ PME, PCr/ATP, PME/PCr PDE/PCr and etc <ref type="bibr" target="#b2">(3,</ref><ref type="bibr" target="#b7">8,</ref><ref type="bibr" target="#b18">19)</ref>.</p><p>The PME and PDE indicated the significance of phospholipid precursors and catabolites as markers for tumor detection, malignancy, progression and the response to treatment <ref type="bibr" target="#b2">(3,</ref><ref type="bibr" target="#b4">5,</ref><ref type="bibr" target="#b19">20)</ref>. The major components of PME are phosphocholine (PCho) and phosphoethanolamine (PEtn) <ref type="bibr" target="#b18">(19)</ref>. These molecules are the intermediates in the biosynthesis of phosphoglycerides and indicate the presence of precursors of cytoplasmic membrane synthesis <ref type="bibr" target="#b20">(21)</ref>. The complete deacylation of phospholipids produce glycerophosphocholine and glycerophosphoethanolamine. These molecules are the major components of PDE, which indicates the presence of breakdown products of the membrane <ref type="bibr" target="#b20">(21,</ref><ref type="bibr" target="#b21">22)</ref>. The ratio of PME/PDE can serve as an index of the metabolism of membrane phospholipid kjronline.org and reflect changes in the rate of membrane synthesis or metabolic turnover <ref type="bibr" target="#b4">(5,</ref><ref type="bibr" target="#b7">8)</ref>. We observed significantly increased PME/PDE ratio in brain tumor as compared to that in the normal brain control group. We also observed a significantly increased PME/PDE ratio in astrocytoma as compared to that in the normal brain. In metastasis, the PME/PDE ratio was significantly higher than that in the normal brain. The PME/PDE ratio in lymphoma was higher than that in the normal brain and astrocytoma, but this was statistically insignificant.</p><p>Unfortunately, these changes have variable limitations in application to the tumors, according to the previous studies. At first, both PME level and PDE level was increased in most tumors <ref type="bibr" target="#b7">(8)</ref>. It seems difficult to understand an accumulation of metabolic precursors with an accelerated formation of end products. Various pathways, enzymes and the roles of PCho and PEtn can affect this paradoxical phenomenon. Furthermore, other studies also showed increased PME levels with using cytostatic agents on the cancer cells, which inhibit proliferation <ref type="bibr" target="#b19">(20,</ref><ref type="bibr" target="#b22">23)</ref>. Moreover, these alterations are not exclusive to malignancy <ref type="bibr" target="#b7">(8)</ref>. These changes may also occur in developing (embryo or fetal) organs, in proliferating tissues, such as regenerating liver, in benign tumors and even in some degenerative pathologies <ref type="bibr" target="#b7">(8)</ref>.</p><p>Variability of peak intensities of the phosphorous metabolite on 31 P MRS was also demonstrated, according to the different origin of the tumors <ref type="bibr" target="#b23">(24)</ref>. In the present study, the PME/PCr and PDE/PCr ratios in lymphoma were also significantly lower than those in the astrocytoma group.</p><p>The PDE/Pi ratio in the lymphoma group was lower than that in control group and the astrocytoma group. The ratio of PDE/PCr in lymphoma was significantly lower than that in astrocytoma. We suspected that this observation may be correlated with the reduced PDE level in lymphoma. The PME/PCr and PDE/PCr ratio in lymphoma were also significantly lower than those in the astrocytoma group. On comparison with the normal control group, the PME/ PCr and PDE/PCr ratios were also reduced, even thought it was statistically insignificant. We considered that this result could be correlated with the increased PCr level in lymphoma. We thought that these changes will be helpful to differentiate the brain tumors.</p><p>There are reports of phosphorous metabolites as markers for the degree of malignancy <ref type="bibr" target="#b2">(3,</ref><ref type="bibr" target="#b5">6)</ref>. In this study, there was no statistically significant parameter that would differentiate between low grade astrocytoma and high grade astrocytoma.</p><p>Another biologic application of 31 P MRS is studying the cellular energy metabolism. ATP, PCr and Pi play crucial roles in cellular energetic <ref type="bibr" target="#b24">(25)</ref><ref type="bibr" target="#b25">(26)</ref><ref type="bibr" target="#b26">(27)</ref>. In a study on brain tumor, the Pi/PCr ratio was significantly elevated and the PCr/ATP ratio was reduced <ref type="bibr" target="#b18">(19)</ref>. The PCr/ATP, PCr/Pi and ATP/Pi ratios in this study were not significantly different between the control group and the brain tumor group, and between each brain lesion.</p><p>In the present study, the MRS signal was obtained by using the FID 2D CSI sequence, collecting FID signal using the CSI sequence. In a classical CSI sequences, the MRS obtains the signal by applying the phase-encoding gradients without a frequency-encoding gradient. Thus, the FID CSI sequence collects a FID, either from the entire sensitive volume of the receiver coil or a prescribed set of slices <ref type="bibr" target="#b27">(28,</ref><ref type="bibr" target="#b28">29)</ref>. As a result, the MRS signals using the FID CSI sequences can be contaminated from normal parenchyma in the outside of the lesion. The MRS signal differences between the tumor and normal tissue can be reduced. For more conservative approach, we performed 31 P MRS on the relatively large sized brain tumor. 31 P magnetic resonance spectroscopy study to the patients with a low field strength equipment like a 1.5 T scanner usually require a long scan time and large voxel, due to low SNR caused by a low concentration of phosphorous metabolite in the lesion <ref type="bibr" target="#b2">(3,</ref><ref type="bibr" target="#b7">8)</ref>. Recently, MRS apparatus has rapidly evolved to perform the study of a relatively small volume of voxel and in a reasonable scan time. We adapted a 27 mL voxel volume and a 6 minutes 36 seconds scan time, with a total scan time of 15 minutes, including the scanning for localization. We designed this study to obtain the MRS signal in vivo as soon as possible and to evaluate the clinical feasibility of 31 P MRS study. This scan time was tolerable for patients to obtain the MR imaging and the MR spectrum in a study. 31 P magnetic resonance spectroscopy study of human brain lesions has shown substantial variability. This variability reported in the literature seemed to have numerous causes. In another previous study (3), masses with a large portion of necrosis were excluded. They suspected that the amount of the necrosis or cystic portion in the brain tumor could create variability of the peak intensities of phosphorous metabolites in the same tumor group. Moreover, the peripheral located voxel and hemorrhage in a lesion may produce magnetic susceptibility artifact that causes a nondiagnostic spectrum or distortion of spectrum. In order to Korean J Radiol 14(3), May/Jun 2013 kjronline.org avoid the possibility of spectrum diversity by these causes, we excluded the brain lesions that have a large cyst, a large necrotic portion, hemorrhage, and were small peripheral located brain lesions, according to the routine brain MRI.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Conclusion</head><p>The clinically applicable 31 P MRS spectrum was obtained with a relatively short scan time and the pH, PME/PDE, PDE/Pi, PME/PCr, and PDE/PCr ratios seem to be useful parameters for the differentiation of the brain tumors.</p></div><figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_0"><head></head><label></label><figDesc>pISSN 1229-6929 • eISSN 2005-8330 Korean J Radiol 14(3), May/Jun 2013 kjronline.org</figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_1"><head>Fig. 1 .</head><label>1</label><figDesc>Flow chart of patient selection. On basis of histopathologic results, patients were classified into 22 cases of brain tumor and 6 cases of abscess. Brain tumors were subdivided into 13 cases of astrocytoma group, 4 cases of lymphoma group, and 5 cases of metastasis group. MRS = magnetic resonance spectroscopy Astrocytoma (n = 13) Lymphoma (n = 4) Metastasis (n = 5)</figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_2"><head>Fig. 2 .Fig. 3 .Fig. 4 .</head><label>234</label><figDesc>Measuring pH in lesion. Intracelluar pH of brain lesions is calculated by using measured δ Pi (arrow), which is chemical shift, from PCr to Pi. PME = phosphomonoester, PDE = phosphodiester, PCr = phosphocreatine, ATP = adenosine triphosphate, Pi = inorganic phosphate 244-year-old man with high grade astrocytoma of brain.A. Localizer image for 31 P MRS shows huge mass in right frontal lobe without cyst or hemorrhage. B. 31 P MRS shows high level of PME (303), low level of Pi (90) and relatively low level of PDE (433). Calculated PME/PDE ratio (0.70) is higher than its mean value in control group (0.47). PME = phosphomonoester, PDE = phosphodiester, PCr = phosphocreatine, MRS = magnetic resonance spectroscopy, Pi = inorganic 53-year-old man with large B cell lymphoma. A. Localizer image for 31 P MRS shows large mass with marked surrounding edema in left basal ganglia area. B. 31 P MRS shows high level of PME (305), high level of PCr (1222) and low level of PDE (373). Calculated ratio shows high PME/PDE ratio (0.81). Calculated PDE/Pi ratio (2.76) is lower than its mean value of control group (3.44) and astrocytoma group(3.27). Calculated PDE/PCr ratio (0.31) is also lower than that of astrocytoma group (0.77). PME = phosphomonoester, PDE = phosphodiester, PCr = phosphocreatine, MRS = magnetic resonance spectroscopy, Pi = inorganic phosphate</figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_3"><head>A Fig. 5 .</head><label>5</label><figDesc>73-year-old man with brain abscess.A. FID signal for 31 P MRS was obtained at left basal ganglia mass lesion.Korean J Radiol 14(3), May/Jun 2013</figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_4"><head>Fig. 5 .</head><label>5</label><figDesc>73-year-old man with brain abscess. B. Fluid-attenuated inversion recovery image shows heterogeneous signal intensity mass with central low signal intensity in left basal ganglia. C. 31 P MRS shows low level of PME (284), low level of PCr (584) and relatively high level of PDE (486). Calculated ratio of PME/PDE (0.58) is lower than its mean value of metastasis group (0.68). FID = free induction decay, PME = phosphomonoester, PDE = phosphodiester, PCr = phosphocreatine, MRS = magnetic resonance spectroscopy, Pi = inorganic phosphate</figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_1"><head>Table 1 . Mean pH and Mean Metabolite Ratios (± SD) between Normal Control Group and Brain Tumor Group</head><label>1</label><figDesc></figDesc><table><row><cell></cell><cell>Normal Control</cell><cell>Brain Tumor</cell><cell></cell></row><row><cell></cell><cell>(n = 11)</cell><cell>(n = 22)</cell><cell>P*</cell></row><row><cell></cell><cell>Mean ± SD</cell><cell>Mean ± SD</cell><cell></cell></row><row><cell>pH</cell><cell>7.07 ± 0.10</cell><cell>7.28 ± 0.27</cell><cell>0.090</cell></row><row><cell>PME/PDE</cell><cell>0.47 ± 0.07</cell><cell>0.57 ± 0.11</cell><cell>0.012</cell></row><row><cell>PME/Pi</cell><cell>1.60 ± 0.19</cell><cell>1.80 ± 0.51</cell><cell>0.178</cell></row><row><cell>PDE/Pi</cell><cell>3.44 ± 0.49</cell><cell>3.16 ± 0.74</cell><cell>0.088</cell></row><row><cell>PME/ATP</cell><cell>0.21 ± 0.03</cell><cell>0.24 ± 0.05</cell><cell>0.261</cell></row><row><cell>PDE/ATP</cell><cell>0.45 ± 0.09</cell><cell>0.43 ± 0.11</cell><cell>0.559</cell></row><row><cell>PME/PCr</cell><cell>0.34 ± 0.07</cell><cell>0.40 ± 0.12</cell><cell>0.178</cell></row><row><cell>PDE/PCr</cell><cell>0.75 ± 0.20</cell><cell>0.72 ± 0.21</cell><cell>0.753</cell></row><row><cell>PCr/ATP</cell><cell>0.61 ± 0.07</cell><cell>0.61 ± 0.14</cell><cell>1.000</cell></row><row><cell>PCr/Pi</cell><cell>4.74 ± 0.74</cell><cell>4.63 ± 1.42</cell><cell>0.445</cell></row><row><cell>ATP/Pi</cell><cell>7.76 ± 0.64</cell><cell>7.93 ± 2.81</cell><cell>0.822</cell></row><row><cell cols="4">Note.-*All p values were calculated by using Mann-Whitney</cell></row><row><cell cols="3">U test. SD = standard deviation, PME = phosphomonoester,</cell><cell></cell></row><row><cell cols="4">PDE = phosphodiester, PCr = phosphocreatine, ATP = adenosine</cell></row><row><cell cols="2">triphosphate, Pi = inorganic phosphate</cell><cell></cell><cell></cell></row></table><note>Korean J Radiol 14(3), May/Jun 2013 kjronline.org</note></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_2"><head>Table 2 . Mean pH and Mean Metabolite Ratios (± SD) in Normal Control Group, Astrocytoma Group, Lymphoma Group, Metastasis Group and Abscess Group Table 3. Significant Differences of pH and Metabolite Ratios between Low Grade Astrocytoma Group and High Grade Astrocytoma Group and between Brain Tumor Group and Abscess Group</head><label>2</label><figDesc></figDesc><table><row><cell></cell><cell>Low Grade vs.</cell><cell>Brain Tumor vs.</cell></row><row><cell></cell><cell>High Grade</cell><cell>Abscess</cell></row><row><cell></cell><cell>Astrocytoma</cell><cell></cell></row><row><cell></cell><cell>P*</cell><cell>P*</cell></row><row><cell>pH</cell><cell>0.575</cell><cell>0.419</cell></row><row><cell>PME/PDE</cell><cell>0.877</cell><cell>0.947</cell></row><row><cell>PME/Pi</cell><cell>0.758</cell><cell>0.689</cell></row><row><cell>PDE/Pi</cell><cell>0.165</cell><cell>0.505</cell></row><row><cell>PME/ATP</cell><cell>0.280</cell><cell>0.182</cell></row><row><cell>PDE/ATP</cell><cell>0.440</cell><cell>0.386</cell></row><row><cell>PME/PCr</cell><cell>1.000</cell><cell>0.594</cell></row><row><cell>PDE/PCr</cell><cell>0.758</cell><cell>0.947</cell></row><row><cell>PCr/ATP</cell><cell>0.877</cell><cell>0.317</cell></row><row><cell>PCr/Pi</cell><cell>0.537</cell><cell>0.594</cell></row><row><cell>ATP/Pi</cell><cell>0.758</cell><cell>0.463</cell></row><row><cell cols="3">Note.-*All p values were calculated by using Mann-Whitney</cell></row><row><cell cols="3">U test. PME = phosphomonoester, PDE = phosphodiester, PCr =</cell></row><row><cell cols="3">phosphocreatine, ATP = adenosine triphosphate, Pi = inorganic</cell></row><row><cell>phosphate</cell><cell></cell><cell></cell></row></table><note>Korean J Radiol 14(3), May/Jun 2013</note></figure>
		</body>
		<back>
			<div type="annex">
<div xmlns="http://www.tei-c.org/ns/1.0"><p>Note.-*All p values were calculated by using Kruskal-Wallis test. SD = standard deviation, PME = phosphomonoester, PDE = phosphodiester, PCr = phosphocreatine, ATP = adenosine triphosphate, Pi = inorganic phosphate</p></div>			</div>
			<div type="references">

				<listBibl>

<biblStruct xml:id="b0">
	<analytic>
		<title level="a" type="main">Monitoring tumor growth and regression by 31P magnetic resonance spectroscopy</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Marion</forename><surname>Stubbs</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Loreta</forename><forename type="middle">M</forename><surname>Rodrigues</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Barry</forename><forename type="middle">A</forename><surname>Gusterson</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">John</forename><forename type="middle">R</forename><surname>Griffiths</surname></persName>
		</author>
		<idno type="DOI">10.1016/0065-2571(90)90019-x</idno>
		<idno type="PMID">2403032</idno>
		<idno type="PII">0065-2571(90)90019-X</idno>
		<idno type="ark">ark:/67375/6H6-FXD0086P-L</idno>
		<idno type="istexId">F847DC36AC20FF9DB5060C968D349B4681AB7533</idno>
	</analytic>
	<monogr>
		<title level="j">Advances in Enzyme Regulation</title>
		<title level="j" type="abbrev">Advances in Enzyme Regulation</title>
		<idno type="ISSN">0065-2571</idno>
		<imprint>
			<biblScope unit="volume">30</biblScope>
			<biblScope unit="page" from="217" to="230" />
			<date type="published" when="1990-01" />
			<publisher>Elsevier BV</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b1">
	<analytic>
		<title level="a" type="main">MR evaluation of response to targeted treatment in cancer cells</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Franca</forename><surname>Podo</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Silvana</forename><surname>Canevari</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Rossella</forename><surname>Canese</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Maria</forename><forename type="middle">Elena</forename><surname>Pisanu</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Alessandro</forename><surname>Ricci</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Egidio</forename><surname>Iorio</surname></persName>
		</author>
		<idno type="DOI">10.1002/nbm.1658</idno>
		<idno type="PMID">21387442</idno>
		<idno type="ark">ark:/67375/WNG-KVD8NCWS-0</idno>
		<idno type="istexId">A5A0F543C954363D5A71B74B6A4C0BC722BA708A</idno>
	</analytic>
	<monogr>
		<title level="j">NMR in Biomedicine</title>
		<title level="j" type="abbrev">NMR Biomed.</title>
		<idno type="ISSN">0952-3480</idno>
		<imprint>
			<biblScope unit="volume">24</biblScope>
			<biblScope unit="page" from="n/a" to="n/a" />
			<date type="published" when="2011" />
			<publisher>Wiley</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b2">
	<analytic>
		<title level="a" type="main">Human in-vivo 31P MR Spectroscopy of Benign and Malignant Breast Tumors</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Jeong</forename><forename type="middle">Mi</forename><surname>Park</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Jae</forename><forename type="middle">Hyung</forename><surname>Park</surname></persName>
		</author>
		<idno type="DOI">10.3348/kjr.2001.2.2.80</idno>
		<idno type="PMID">11752975</idno>
		<idno type="PMCID">PMC2718106</idno>
		<ptr type="open-access" target="http://synapse.koreamed.org/Synapse/Data/PDFData/0068KJR/kjr-2-80.pdf" />
	</analytic>
	<monogr>
		<title level="j">Korean Journal of Radiology</title>
		<title level="j" type="abbrev">Korean J Radiol</title>
		<idno type="ISSN">1229-6929</idno>
		<imprint>
			<biblScope unit="volume">2</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page">80</biblScope>
			<date type="published" when="2001" />
			<publisher>The Korean Society of Radiology (KAMJE)</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b3">
	<analytic>
		<title level="a" type="main">Phospholipid and Energy Metabolism of Cancer Cells Monitored by 31P Magnetic Resonance Spectroscopy: Possible Clinical Significance</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Jack</forename><forename type="middle">S</forename><surname>Cohen</surname></persName>
		</author>
		<idno type="DOI">10.1016/s0025-6196(12)65406-8</idno>
		<idno type="PMID">3059078</idno>
		<ptr type="open-access" target="http://www.mayoclinicproceedings.org/article/S0025619612654068/pdf" />
	</analytic>
	<monogr>
		<title level="j">Mayo Clinic Proceedings</title>
		<title level="j" type="abbrev">Mayo Clinic Proceedings</title>
		<idno type="ISSN">0025-6196</idno>
		<imprint>
			<biblScope unit="volume">63</biblScope>
			<biblScope unit="issue">12</biblScope>
			<biblScope unit="page" from="1199" to="1207" />
			<date type="published" when="1988-12" />
			<publisher>Elsevier BV</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b4">
	<analytic>
		<title level="a" type="main">1H- and31P-MR spectroscopy of primary and recurrent human brain tumorsin vitro: malignancy-characteristic profiles of water soluble and lipophilic spectral components</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Fritz-Georg</forename><surname>Lehnhardt</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Gabriele</forename><surname>Röhn</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Ralf-Ingo</forename><surname>Ernestus</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Matthias</forename><surname>Grüne</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Mathias</forename><surname>Hoehn</surname></persName>
		</author>
		<idno type="DOI">10.1002/nbm.708</idno>
		<idno type="PMID">11477651</idno>
		<idno type="ark">ark:/67375/WNG-VCS4NP29-N</idno>
		<idno type="istexId">FEF9E92F19C21D517CD32F42A0DC553DF3F27F1D</idno>
	</analytic>
	<monogr>
		<title level="j">NMR in Biomedicine</title>
		<title level="j" type="abbrev">NMR Biomed.</title>
		<idno type="ISSN">0952-3480</idno>
		<imprint>
			<biblScope unit="volume">14</biblScope>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page" from="307" to="317" />
			<date type="published" when="2001-07-10" />
			<publisher>Wiley</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b5">
	<analytic>
		<title level="a" type="main">Positron emission tomography of fluorine-18-deoxyglucose and image-guided phosphorus-31 magnetic resonance spectroscopy in brain tumors</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">W</forename><forename type="middle">D</forename><surname>Heiss</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">W</forename><surname>Heindel</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">K</forename><surname>Herholz</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Rudolf</forename><forename type="middle">J</forename><surname>Bunke</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><surname>Jeske</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Nucl Med</title>
		<imprint>
			<biblScope unit="volume">31</biblScope>
			<biblScope unit="page" from="302" to="310" />
			<date type="published" when="1990" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b6">
	<analytic>
		<title level="a" type="main">The Investigation of Experimental Brain Tumours Using 31P-MRS and 1H-MRI</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Kimiyoshi</forename><surname>Hirakawa</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><forename type="middle">H</forename><surname>Naruse</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">T</forename><surname>Higuchi</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Y</forename><surname>Horikawa</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">C</forename><forename type="middle">H</forename><surname>Tanaka</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">T</forename><surname>Ebisu</surname></persName>
		</author>
		<idno type="DOI">10.1007/978-3-7091-8978-8_30</idno>
	</analytic>
	<monogr>
		<title level="m">Proceedings of the 8th European Congress of Neurosurgery, Barcelona, September 6–11, 1987</title>
		<meeting>the 8th European Congress of Neurosurgery, Barcelona, September 6–11, 1987</meeting>
		<imprint>
			<publisher>Springer Vienna</publisher>
			<date type="published" when="1988" />
			<biblScope unit="volume">43</biblScope>
			<biblScope unit="page" from="140" to="144" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b7">
	<analytic>
		<title level="a" type="main">Phosphorus-31 MR spectroscopy of normal adult human brain and brain tumours</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">David</forename><surname>Maintz</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Walter</forename><surname>Heindel</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Harald</forename><surname>Kugel</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Richard</forename><surname>Jaeger</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Klaus</forename><forename type="middle">J</forename><surname>Lackner</surname></persName>
		</author>
		<idno type="DOI">10.1002/nbm.735</idno>
		<idno type="PMID">11840549</idno>
		<idno type="ark">ark:/67375/WNG-TPWKH45F-J</idno>
		<idno type="istexId">D451F99427946B71281C834F55C8710AE5D885A1</idno>
	</analytic>
	<monogr>
		<title level="j">NMR in Biomedicine</title>
		<title level="j" type="abbrev">NMR Biomed.</title>
		<idno type="ISSN">0952-3480</idno>
		<idno type="ISSNe">1099-1492</idno>
		<imprint>
			<biblScope unit="volume">15</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="18" to="27" />
			<date type="published" when="2002" />
			<publisher>Wiley</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b8">
	<analytic>
		<title level="a" type="main">In vivo31P MR spectral patterns and reproducibility in cancer patients studied in a multi-institutional trial</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">F</forename><surname>Arias-Mendoza</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">G</forename><forename type="middle">S</forename><surname>Payne</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">K</forename><forename type="middle">L</forename><surname>Zakian</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><forename type="middle">J</forename><surname>Schwarz</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><surname>Stubbs</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">R</forename><surname>Stoyanova</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">D</forename><surname>Ballon</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">F</forename><forename type="middle">A</forename><surname>Howe</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><forename type="middle">A</forename><surname>Koutcher</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><forename type="middle">O</forename><surname>Leach</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><forename type="middle">R</forename><surname>Griffiths</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><surname>Heerschap</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><forename type="middle">D</forename><surname>Glickson</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><forename type="middle">J</forename><surname>Nelson</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><forename type="middle">L</forename><surname>Evelhoch</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">H</forename><forename type="middle">C</forename><surname>Charles</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">T</forename><forename type="middle">R</forename><surname>Brown</surname></persName>
		</author>
		<idno type="DOI">10.1002/nbm.1057</idno>
		<idno type="PMID">16763965</idno>
		<idno type="ark">ark:/67375/WNG-0TKNQF7L-S</idno>
		<idno type="istexId">AF59C26F01F25E34F7FA0324E6541793A0226D99</idno>
	</analytic>
	<monogr>
		<title level="j">NMR in Biomedicine</title>
		<title level="j" type="abbrev">NMR Biomed.</title>
		<idno type="ISSN">0952-3480</idno>
		<idno type="ISSNe">1099-1492</idno>
		<imprint>
			<biblScope unit="volume">19</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="504" to="512" />
			<date type="published" when="2006" />
			<publisher>Wiley</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b9">
	<analytic>
		<title level="a" type="main">Human neoplasm pH and response to radiation therapy: P-31 MR spectroscopy studies in situ.</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">T</forename><forename type="middle">C</forename><surname>Ng</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><forename type="middle">W</forename><surname>Majors</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><surname>Vijayakumar</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">N</forename><forename type="middle">J</forename><surname>Baldwin</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">F</forename><forename type="middle">J</forename><surname>Thomas</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">I</forename><surname>Koumoundouros</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><forename type="middle">E</forename><surname>Taylor</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><forename type="middle">F</forename><surname>Grundfest</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">T</forename><forename type="middle">F</forename><surname>Meaney</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">R</forename><forename type="middle">R</forename><surname>Tubbs</surname></persName>
		</author>
		<idno type="DOI">10.1148/radiology.170.3.2916046</idno>
		<idno type="PMID">2916046</idno>
	</analytic>
	<monogr>
		<title level="j">Radiology</title>
		<title level="j" type="abbrev">Radiology</title>
		<idno type="ISSN">0033-8419</idno>
		<idno type="ISSNe">1527-1315</idno>
		<imprint>
			<biblScope unit="volume">170</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="875" to="878" />
			<date type="published" when="1989-03" />
			<publisher>Radiological Society of North America (RSNA)</publisher>
		</imprint>
	</monogr>
	<note>Pt 1</note>
</biblStruct>

<biblStruct xml:id="b10">
	<analytic>
		<title level="a" type="main">MR spectroscopy of bilateral thalamic gliomas</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">F</forename><surname>Estève</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><surname>Grand</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">C</forename><surname>Rubin</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">D</forename><surname>Hoffmann</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">B</forename><surname>Pasquier</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">D</forename><surname>Graveron-Demilly</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">AJNR Am J Neuroradiol</title>
		<imprint>
			<biblScope unit="volume">20</biblScope>
			<biblScope unit="page" from="876" to="881" />
			<date type="published" when="1999" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b11">
	<analytic>
		<title level="a" type="main">The study of human organs by phosphorus-31 topical magnetic resonance spectroscopy</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Rolf</forename><forename type="middle">D</forename><surname>Oberhaensli</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Graham</forename><forename type="middle">J</forename><surname>Galloway</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">David</forename><surname>Hilton-Jones</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Peter</forename><forename type="middle">J</forename><surname>Bore</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Peter</forename><surname>Styles</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Bheeshma</forename><surname>Rajagopalan</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Doris</forename><forename type="middle">J</forename><surname>Taylor</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">George</forename><forename type="middle">K</forename><surname>Radda</surname></persName>
		</author>
		<idno type="DOI">10.1259/0007-1285-60-712-367</idno>
		<idno type="PMID">3580743</idno>
	</analytic>
	<monogr>
		<title level="j">The British Journal of Radiology</title>
		<title level="j" type="abbrev">BJR</title>
		<idno type="ISSN">0007-1285</idno>
		<idno type="ISSNe">1748-880X</idno>
		<imprint>
			<biblScope unit="volume">60</biblScope>
			<biblScope unit="issue">712</biblScope>
			<biblScope unit="page" from="367" to="373" />
			<date type="published" when="1987-04" />
			<publisher>British Institute of Radiology</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b12">
	<analytic>
		<title level="a" type="main">A quantitative analysis of the accuracy ofIn Vivo pH measurements with31P NMR spectroscopy: Assessment of pH measurement methodology</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><surname>Madden</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><forename type="middle">O</forename><surname>Leach</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><forename type="middle">C</forename><surname>Sharp</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">D</forename><forename type="middle">J</forename><surname>Collins</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">D</forename><surname>Easton</surname></persName>
		</author>
		<idno type="DOI">10.1002/nbm.1940040102</idno>
		<idno type="PMID">2029454</idno>
		<idno type="ark">ark:/67375/WNG-XM5C25XH-P</idno>
		<idno type="istexId">53CF66FF83117D0E48336CA7CB194038CE69EE5E</idno>
	</analytic>
	<monogr>
		<title level="j">NMR in Biomedicine</title>
		<title level="j" type="abbrev">NMR Biomed.</title>
		<idno type="ISSN">0952-3480</idno>
		<idno type="ISSNe">1099-1492</idno>
		<imprint>
			<biblScope unit="volume">4</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="1" to="11" />
			<date type="published" when="1991-02" />
			<publisher>Wiley</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b13">
	<analytic>
		<title level="a" type="main">MRI of the tumor microenvironment</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Robert</forename><forename type="middle">J</forename><surname>Gillies</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Natarajan</forename><surname>Raghunand</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Gregory</forename><forename type="middle">S</forename><surname>Karczmar</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Zaver</forename><forename type="middle">M</forename><surname>Bhujwalla</surname></persName>
		</author>
		<idno type="DOI">10.1002/jmri.10181</idno>
		<idno type="PMID">12353258</idno>
		<idno type="ark">ark:/67375/WNG-8H89X4N8-Q</idno>
		<idno type="istexId">2B5F85BE98E10B60F00DF5B6AC241146C7E5502C</idno>
	</analytic>
	<monogr>
		<title level="j">Journal of Magnetic Resonance Imaging</title>
		<title level="j" type="abbrev">J. Magn. Reson. Imaging</title>
		<idno type="ISSN">1053-1807</idno>
		<idno type="ISSNe">1522-2586</idno>
		<imprint>
			<biblScope unit="volume">16</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="430" to="450" />
			<date type="published" when="2002-09-25" />
			<publisher>Wiley</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b14">
	<analytic>
		<title level="a" type="main">Are cancer cells acidic?</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><forename type="middle">R</forename><surname>Griffiths</surname></persName>
		</author>
		<idno type="DOI">10.1038/bjc.1991.326</idno>
		<idno type="PMID">1911181</idno>
		<idno type="PMCID">PMC1977628</idno>
		<ptr type="open-access" target="https://www.nature.com/articles/bjc1991326.pdf" />
	</analytic>
	<monogr>
		<title level="j">British Journal of Cancer</title>
		<title level="j" type="abbrev">Br J Cancer</title>
		<idno type="ISSN">0007-0920</idno>
		<idno type="ISSNe">1532-1827</idno>
		<imprint>
			<biblScope unit="volume">64</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="425" to="427" />
			<date type="published" when="1991-09" />
			<publisher>Springer Nature</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b15">
	<analytic>
		<title level="a" type="main">Studies of human tumors by MRS: A review</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">William</forename><surname>Negendank</surname></persName>
		</author>
		<idno type="DOI">10.1002/nbm.1940050518</idno>
		<idno type="PMID">1333263</idno>
		<idno type="ark">ark:/67375/WNG-SBXQC66C-K</idno>
		<idno type="istexId">CA552CD6195453ED42582D25F6C293156AD22581</idno>
	</analytic>
	<monogr>
		<title level="j">NMR in Biomedicine</title>
		<title level="j" type="abbrev">NMR Biomed.</title>
		<idno type="ISSN">0952-3480</idno>
		<imprint>
			<biblScope unit="volume">5</biblScope>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page" from="303" to="324" />
			<date type="published" when="1992-09" />
			<publisher>Wiley</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b16">
	<analytic>
		<title level="a" type="main">P-31 MR spectroscopy of normal human brain and brain tumors.</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">B</forename><surname>Hubesch</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">D</forename><surname>Sappey-Marinier</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">K</forename><surname>Roth</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">D</forename><forename type="middle">J</forename><surname>Meyerhoff</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">G</forename><forename type="middle">B</forename><surname>Matson</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><forename type="middle">W</forename><surname>Weiner</surname></persName>
		</author>
		<idno type="DOI">10.1148/radiology.174.2.2296651</idno>
		<idno type="PMID">2296651</idno>
	</analytic>
	<monogr>
		<title level="j">Radiology</title>
		<title level="j" type="abbrev">Radiology</title>
		<idno type="ISSN">0033-8419</idno>
		<idno type="ISSNe">1527-1315</idno>
		<imprint>
			<biblScope unit="volume">174</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="401" to="409" />
			<date type="published" when="1990-02" />
			<publisher>Radiological Society of North America (RSNA)</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b17">
	<analytic>
		<title level="a" type="main">Regional metabolism in experimental brain tumors in cats: relationship with acid/base, water, and electrolyte homeostasis</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Yoshikazu</forename><surname>Okada</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Otmar</forename><surname>Kloiber</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Konstantin</forename><forename type="middle">A</forename><surname>Hossmann</surname></persName>
		</author>
		<idno type="DOI">10.3171/jns.1992.77.6.0917</idno>
		<idno type="PMID">1432136</idno>
		<ptr type="open-access" target="http://pdfs.semanticscholar.org/6d52/6975dd0924b7ecce4329f35b2dbf49c12751.pdf" />
	</analytic>
	<monogr>
		<title level="j">Journal of Neurosurgery</title>
		<title level="j" type="abbrev">Journal of Neurosurgery</title>
		<idno type="ISSN">0022-3085</idno>
		<imprint>
			<biblScope unit="volume">77</biblScope>
			<biblScope unit="issue">6</biblScope>
			<biblScope unit="page" from="917" to="926" />
			<date type="published" when="1992-12" />
			<publisher>Journal of Neurosurgery Publishing Group (JNSPG)</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b18">
	<analytic>
		<title level="a" type="main">Proton-decoupled31P MRS in untreated pediatric brain tumors</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Mark</forename><forename type="middle">J</forename><surname>Albers</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Mark</forename><forename type="middle">D</forename><surname>Krieger</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Ignacio</forename><surname>Gonzalez-Gomez</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Floyd</forename><forename type="middle">H</forename><surname>Gilles</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><forename type="middle">Gordon</forename><surname>Mccomb</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Marvin</forename><forename type="middle">D</forename><surname>Nelson</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Stefan</forename><surname>Blüml</surname></persName>
		</author>
		<idno type="DOI">10.1002/mrm.20312</idno>
		<idno type="PMID">15690498</idno>
		<idno type="ark">ark:/67375/WNG-4WPVWXSQ-B</idno>
		<idno type="istexId">01590B0F7620931FCC41CC030990016EF31E1581</idno>
	</analytic>
	<monogr>
		<title level="j">Magnetic Resonance in Medicine</title>
		<title level="j" type="abbrev">Magn. Reson. Med.</title>
		<idno type="ISSN">0740-3194</idno>
		<imprint>
			<biblScope unit="volume">53</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="22" to="29" />
			<date type="published" when="2004-12-22" />
			<publisher>Wiley</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b19">
	<analytic>
		<title level="a" type="main">Metabolic studies of estrogen-and tamoxifen-treated human breast cancer cells by nuclear magnetic resonance spectroscopy</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><surname>Neeman</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">H</forename><surname>Degani</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cancer Res</title>
		<imprint>
			<biblScope unit="volume">49</biblScope>
			<biblScope unit="page" from="589" to="594" />
			<date type="published" when="1989" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b20">
	<analytic>
		<title level="a" type="main">MR spectroscopy: clinical perspective.</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><forename type="middle">M</forename><surname>Aisen</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">T</forename><forename type="middle">L</forename><surname>Chenevert</surname></persName>
		</author>
		<idno type="DOI">10.1148/radiology.173.3.2682768</idno>
		<idno type="PMID">2682768</idno>
	</analytic>
	<monogr>
		<title level="j">Radiology</title>
		<title level="j" type="abbrev">Radiology</title>
		<idno type="ISSN">0033-8419</idno>
		<idno type="ISSNe">1527-1315</idno>
		<imprint>
			<biblScope unit="volume">173</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="593" to="599" />
			<date type="published" when="1989-12" />
			<publisher>Radiological Society of North America (RSNA)</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b21">
	<analytic>
		<title level="a" type="main">Tumour phospholipid metabolism</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">F</forename><surname>Podo</surname></persName>
		</author>
		<idno type="DOI">10.1002/(sici)1099-1492(199911)12:7&lt;413::aid-nbm587&gt;3.0.co;2-u</idno>
		<idno type="PMID">10654290</idno>
		<idno type="ark">ark:/67375/WNG-JMMH6ZV5-F</idno>
		<idno type="istexId">DA4BBE0AAA40E12084E7DEA931423883BF4F690B</idno>
	</analytic>
	<monogr>
		<title level="j">NMR in Biomedicine</title>
		<title level="j" type="abbrev">NMR Biomed.</title>
		<idno type="ISSN">0952-3480</idno>
		<idno type="ISSNe">1099-1492</idno>
		<imprint>
			<biblScope unit="volume">12</biblScope>
			<biblScope unit="issue">7</biblScope>
			<biblScope unit="page" from="413" to="439" />
			<date type="published" when="1999-11" />
			<publisher>Wiley</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b22">
	<analytic>
		<title level="a" type="main">Inhibition of Tumor Cell Proliferation by Dexamethasone: 31P NMR Studies of RIF-1 Fibrosarcoma Cells Perfused In Vitro</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Aida</forename><surname>Abraha</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Hyunsuk</forename><surname>Shim</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Janna</forename><forename type="middle">P</forename><surname>Wehrle</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Jerry</forename><forename type="middle">D</forename><surname>Glickson</surname></persName>
		</author>
		<idno type="DOI">10.1002/(sici)1099-1492(199606)9:4&lt;173::aid-nbm402&gt;3.3.co;2-a</idno>
	</analytic>
	<monogr>
		<title level="j">NMR in Biomedicine</title>
		<title level="j" type="abbrev">NMR Biomed.</title>
		<idno type="ISSN">0952-3480</idno>
		<idno type="ISSNe">1099-1492</idno>
		<imprint>
			<biblScope unit="volume">9</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="173" to="178" />
			<date type="published" when="1996-06" />
			<publisher>Wiley</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b23">
	<analytic>
		<title level="a" type="main">Characterization of astrocytomas, meningiomas, and pituitary adenomas by phosphorus magnetic resonance spectroscopy</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Douglas</forename><forename type="middle">L</forename><surname>Arnold</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Joseph</forename><forename type="middle">F</forename><surname>Emrich</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Eric</forename><forename type="middle">A</forename><surname>Shoubridge</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Jean-Guy</forename><surname>Villemure</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">William</forename><surname>Feindel</surname></persName>
		</author>
		<idno type="DOI">10.3171/jns.1991.74.3.0447</idno>
		<idno type="PMID">1993910</idno>
		<ptr type="open-access" target="http://pdfs.semanticscholar.org/e911/549c1f5abc5789cbf76875c96335469542b1.pdf" />
	</analytic>
	<monogr>
		<title level="j">Journal of Neurosurgery</title>
		<title level="j" type="abbrev">Journal of Neurosurgery</title>
		<idno type="ISSN">0022-3085</idno>
		<imprint>
			<biblScope unit="volume">74</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="447" to="453" />
			<date type="published" when="1991-03" />
			<publisher>Journal of Neurosurgery Publishing Group (JNSPG)</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b24">
	<analytic>
		<title level="a" type="main">Absolute quantification of phosphorus metabolite concentrations in human musclein vivo by31P MRS: a quantitative review</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Graham</forename><forename type="middle">J</forename><surname>Kemp</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Martin</forename><surname>Meyerspeer</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Ewald</forename><surname>Moser</surname></persName>
		</author>
		<idno type="DOI">10.1002/nbm.1192</idno>
		<idno type="PMID">17628042</idno>
		<idno type="ark">ark:/67375/WNG-7FQR7GDJ-B</idno>
		<idno type="istexId">3225B2CE135ED1A46E35C8544E3C07ADAE337641</idno>
	</analytic>
	<monogr>
		<title level="j">NMR in Biomedicine</title>
		<title level="j" type="abbrev">NMR Biomed.</title>
		<idno type="ISSN">0952-3480</idno>
		<idno type="ISSNe">1099-1492</idno>
		<imprint>
			<biblScope unit="volume">20</biblScope>
			<biblScope unit="issue">6</biblScope>
			<biblScope unit="page" from="555" to="565" />
			<date type="published" when="2007" />
			<publisher>Wiley</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b25">
	<analytic>
		<title level="a" type="main">Cardiac 31P-MRS compared to echocardiographic findings in patients with hypertensive heart disease without overt systolic dysfunction—Preliminary results</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Thorsten</forename><surname>Burkhard</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Christopher</forename><surname>Herzog</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Sven</forename><surname>Linzbach</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Ioakim</forename><surname>Spyridopoulos</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Frank</forename><surname>Huebner</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Thomas</forename><forename type="middle">J</forename><surname>Vogl</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.ejrad.2008.03.022</idno>
		<idno type="PMID">18485651</idno>
	</analytic>
	<monogr>
		<title level="j">European Journal of Radiology</title>
		<title level="j" type="abbrev">European Journal of Radiology</title>
		<idno type="ISSN">0720-048X</idno>
		<imprint>
			<biblScope unit="volume">71</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="69" to="74" />
			<date type="published" when="2009-07" />
			<publisher>Elsevier BV</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b26">
	<analytic>
		<title level="a" type="main">Normal Cortical Energy Metabolism in Migrainous Stroke: A 31P-MR Spectroscopy Study</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">U</forename><forename type="middle">G</forename><surname>Schulz</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><forename type="middle">M</forename><surname>Blamire</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">P</forename><surname>Davies</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">P</forename><surname>Styles</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">P</forename><forename type="middle">M</forename><surname>Rothwell</surname></persName>
		</author>
		<idno type="DOI">10.1161/strokeaha.109.558163</idno>
		<idno type="PMID">19834021</idno>
		<ptr type="open-access" target="https://www.ahajournals.org/doi/pdf/10.1161/STROKEAHA.109.558163" />
	</analytic>
	<monogr>
		<title level="j">Stroke</title>
		<title level="j" type="abbrev">Stroke</title>
		<idno type="ISSN">0039-2499</idno>
		<idno type="ISSNe">1524-4628</idno>
		<imprint>
			<biblScope unit="volume">40</biblScope>
			<biblScope unit="issue">12</biblScope>
			<biblScope unit="page" from="3740" to="3744" />
			<date type="published" when="2009-10-15" />
			<publisher>Ovid Technologies (Wolters Kluwer Health)</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b27">
	<analytic>
		<title level="a" type="main">Spectroscopic imaging: Basic principles</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Antonin</forename><surname>Skoch</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Filip</forename><surname>Jiru</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Jürgen</forename><surname>Bunke</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.ejrad.2008.03.003</idno>
		<idno type="PMID">18434063</idno>
	</analytic>
	<monogr>
		<title level="j">European Journal of Radiology</title>
		<title level="j" type="abbrev">European Journal of Radiology</title>
		<idno type="ISSN">0720-048X</idno>
		<imprint>
			<biblScope unit="volume">67</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="230" to="239" />
			<date type="published" when="2008-08" />
			<publisher>Elsevier BV</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b28">
	<analytic>
		<title level="a" type="main">The performance of volume selection sequences for in vivo NMR spectroscopy: implications for quantitative MRS</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Stephen</forename><forename type="middle">F</forename><surname>Keevil</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Marcus</forename><forename type="middle">C</forename><surname>Newbold</surname></persName>
		</author>
		<idno type="DOI">10.1016/s0730-725x(01)00449-0</idno>
		<idno type="PMID">11755732</idno>
		<idno type="PII">S0730-725X(01)00449-0</idno>
		<idno type="ark">ark:/67375/6H6-RC7KS9WD-G</idno>
		<idno type="istexId">2B2DA0A8C2A9A6C07FE0C44E86432C6DD46F0B12</idno>
	</analytic>
	<monogr>
		<title level="j">Magnetic Resonance Imaging</title>
		<title level="j" type="abbrev">Magnetic Resonance Imaging</title>
		<idno type="ISSN">0730-725X</idno>
		<imprint>
			<biblScope unit="volume">19</biblScope>
			<biblScope unit="issue">9</biblScope>
			<biblScope unit="page" from="1217" to="1226" />
			<date type="published" when="2001-11" />
			<publisher>Elsevier BV</publisher>
		</imprint>
	</monogr>
</biblStruct>

				</listBibl>
			</div>
		</back>
	</text>
</TEI>
